Markets:

Overview

News

Currencies

International

Treasuries

CorMedix Inc. - Common Stock (NQ:CRMD)

9.680 -0.040 (-0.41%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CorMedix Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 30, 2024

Via Benzinga

Biotech Momentum Trades For The Q4 Rally ↗

October 29, 2024

The biotech sector made an interim peak in late February followed by an active summer in very choppy trading.

Via Talk Markets

Earnings Preview For Cormedix ↗

October 29, 2024

Via Benzinga

Biotech Stocks : Are You A Trader Or A Longer Term Investor? ↗

October 01, 2024

Biotech bull market is intact as indicated by large cap biopharma and the best performing funds.

Via Talk Markets

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday ↗

August 26, 2024

Via Benzinga

CRMD Stock Earnings: Cormedix Beats EPS for Q1 2024 ↗

May 09, 2024

CRMD stock results show that Cormedix beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Cormedix Earnings Preview ↗

March 11, 2024

Via Benzinga

Why CorMedix Stock Popped Wednesday ↗

November 15, 2023

CorMedix Inc. (NASDAQ: CRMD) shares traded higher Wednesday after the company reported better-than-expected third-quarter earnings results.

Via Benzinga

CorMedix (CRMD) Q2 2024 Earnings Call Transcript ↗

August 14, 2024

CRMD earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

CRMD Stock Earnings: Cormedix Meets EPS, Misses Revenue for Q2 2024 ↗

August 14, 2024

CRMD stock results show that Cormedix met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Trading SMID Biotech Stocks In A Volatile Market ↗

July 01, 2024

Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...

Via Talk Markets

CorMedix (CRMD) Q1 2024 Earnings Call Transcript ↗

May 09, 2024

CRMD earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential ↗

April 15, 2024

With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.

Via InvestorPlace

CorMedix Inc. (NASDAQ: CRMD) Leading the Way in Wednesday Trading Based on Percentage Gain

November 15, 2023

Via Investor Brand Network

The Latest Analyst Ratings for Cormedix ↗

August 10, 2023

Via Benzinga

CorMedix (CRMD) Q2 2023 Earnings Call Transcript ↗

August 08, 2023

CRMD earnings call for the period ending June 30, 2023.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 12, 2024

Via Benzinga

CorMedix (CRMD) Q4 2023 Earnings Call Transcript ↗

March 12, 2024

CRMD earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For March 12, 2024 ↗

March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Via Benzinga

Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 15, 2023

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 15, 2023

Via Benzinga

Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday ↗

November 15, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: TGT) jumped during Wednesday’s session after the company reported...

Via Benzinga

Topics Earnings Stocks

Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket ↗

November 15, 2023

Shares of CorMedix Inc. (NASDAQ: CRMD) surged in pre-market trading as the company posted a narrower-than-expected third-quarter loss. Cormedix posted a loss of 17 cents per share for the third...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 15, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 15, 2023

It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news worth reading about on Wednesday!

Via InvestorPlace

CorMedix (CRMD) Q3 2023 Earnings Call Transcript ↗

November 14, 2023

CRMD earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

10 Health Care Stocks Whale Activity In Today's Session ↗

October 11, 2023

Via Benzinga

CorMedix's DefenCath Aims to Tackle Catheter-Related Blood Stream Infections: Analyst ↗

August 10, 2023

RBC Capital Markets initiated coverage on CorMedix Inc (NASDAQ: CRMD) with an Outperform rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023 ↗

August 10, 2023

Via Benzinga

Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 29, 2023

Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CorMedix Inc. - Common Stock (NQ:CRMD)

All News about CorMedix Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today